Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-β-dependent mechanism in diffuse-type gastric cancer cells

European Journal of Cancer

Volumn 46, Issue 5, 2010, Pages 995-1005

  Noda, Satoru ^a   Yashiro, Masakazu ^a   Nshii, Takafumi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion; Gastric cancer; Hypoxia; Integrin; TGF

Indexed keywords

ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECEPTOR BLOCKING AGENT; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER CELL; CELL ADHESION; CELL HYPOXIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PERITONEUM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; UPREGULATION;

ANTIBODIES, NEUTRALIZING; BENZAMIDES; CELL ADHESION; CELL HYPOXIA; CELL LINE, TUMOR; DIOXOLES; HUMANS; INTEGRINS; NEOPLASM PROTEINS; PERITONEAL NEOPLASMS; PHOSPHORYLATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77349100347     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.01.007     Document Type: Article

References (29)

1. Lunt S.J., Chaudary N., and Hill R.P. The tumor microenvironment and metastatic disease. Clin Exp Metastasis 26 1 (2009) 19-34
2. Hockel M., Schlenger K., Hockel S., et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59 18 (1999) 4525-4528
3. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59 22 (1999) 5830-5835
4. Subarsky P., and Hill R.P. Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells. Clin Exp Metastasis 25 3 (2008) 253-264
5. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 19 (1996) 4509-4515
6. Griffiths E.A., Pritchard S.A., Valentine H.R., et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer 96 1 (2007) 95-103
7. Griffiths E.A., Pritchard S.A., Welch I.M., et al. Is the hypoxia-inducible factor pathway important in gastric cancer?. Eur J Cancer 41 18 (2005) 2792-2805
8. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
9. Chen C.Y., Wu C.W., Lo S.S., et al. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology 49 45 (2002) 874-877
10. Ikeguchi M., Yamamoto O., and Kaibara N. Management protocol for scirrhous gastric cancer. In Vivo 18 5 (2004) 577-580
11. Nakamura K., Yashiro M., Matsuoka T., et al. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for scirrhous gastric cancer. Gastroenterology 131 5 (2006) 1530-1541
12. Yashiro M., Chung Y.S., Nishimura S., et al. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer 72 5 (1995) 1200-1210
13. Nishimura S., Chung Y.S., Yashiro M., et al. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74 9 (1996) 1406-1412
14. Bando E., Yonemura Y., Takeshita Y., et al. Intraoperative lavage for cytological examination in 1, 297 patients with gastric carcinoma. Am J Surg 178 3 (1999) 256-262
15. Kizaka-Kondoh S., Itasaka S., Zeng L., et al. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer. Clin Cancer Res 15 10 (2009) 3433-3441
16. Matsuoka T., Yashiro M., Nishimura S., et al. Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma. Int J Mol Med 5 1 (2000) 21-25
17. Koyama T., Yashiro M., Inoue T., et al. TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. Int J Oncol 16 2 (2000) 355-362
18. Kawajiri H., Yashiro M., Shinto O., et al. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 14 9 (2008) 2850-2860
19. Irigoyen M., Anso E., Salvo E., et al. TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions. Cell Mol Life Sci 65 14 (2008) 2244-2255
20. Takemura S., Yashiro M., Sunami T., Tendo M., and Hirakawa K. Novel models for human scirrhous gastric carcinoma in vivo. Cancer Sci 95 11 (2004) 893-900
21. Sekiguchi M., Sakakibara K., and Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48 1 (1978) 61-68
22. Motoyama T., Hojo H., and Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36 1 (1986) 65-83
23. Nakashio T., Narita T., Akiyama S., et al. Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Int J Cancer 70 5 (1997) 612-618
24. Rohwer N., Welzel M., Daskalow K., et al. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res 68 24 (2008) 10113-10120
25. Spangenberg C., Lausch E.U., Trost T.M., et al. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. Cancer Res 66 7 (2006) 3715-3725
26. Kong F., Garcia A.J., and Mould A.P. Demonstration of catch bonds between an integrin and its ligand. J Cell Biol 185 7 (2009) 1275-1284
27. Ijichi H., Ikenoue T., Kato N., et al. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun 289 2 (2001) 350-357
28. Yamamoto M., Maehara Y., Sakaguchi Y., et al. Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer 77 8 Suppl. (1996) 1628-1633
29. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 10 (2003) 721-732